Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

Celgene

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.

Novartis trial marks ResearchKit first in MS

Novartis trial marks ResearchKit first in MS

ElevateMS study will allow participants to contribute from smartphones

Celgene steps back from $1bn Sutro acquisition

Celgene steps back from $1bn Sutro acquisition Celgene steps back from $1bn Sutro acquisition. Instead opts for amended licensing deal with US biotech. ... Celgene has decided not to acquire US biotech Sutro Biopharma, opting instead for an amended licensing deal with the cancer immunotherapy

Teva to cut 7000 jobs, close 15 manufacturing sites

Teva to cut 7000 jobs, close 15 manufacturing sites According to a Financial Times report, both AstraZeneca's Pascal Soriot and Jacqualyn Fouse, formerly chief operating officer at Celgene, have turned down the job.

Celgene, Agios get FDA OK for leukaemia drug Idhifa

Celgene, Agios get FDA OK for leukaemia drug Idhifa Celgene, Agios get FDA OK for leukaemia drug Idhifa. Duo’s drug becomes first new AML therapy since Novartis' Rydapt. ... That kicked off in 2010 with a $130m upfront payment from Celgene to Agios.

Celgene joins PD-1 race via partnership with BeiGene

Celgene joins PD-1 race via partnership with BeiGene Celgene joins PD-1 race via partnership with BeiGene. The pharma giant will pay the Chinese firm up to $980m in milestone payments. ... Celgene has an earlier $450m deal with AstraZeneca on PD-L1 inhibitor durvalumab, just rolling out in its first markets

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. We are an award-winning agency with over 30...

Latest intelligence

The_Pharma_Wars_Series.png
The Pharma Wars Series
The future galaxy is complex. Where markets are more competitive and customers more segmented, you’ve got to be smarter. But not only smarter, the Jedi today needs to be everywhere...
What pharma marketers can learn from growth hacking?
Growth hackers instinctively blend technical skills with creative thinking...
Medicines for Europe
The sound of silence puts the squeeze on generics and biosimilars
Medicines for Europe vows to get governments talking to realise potential...

Infographics